23-Dihydroxybenzoic acid

CAS No. 303-38-8

23-Dihydroxybenzoic acid ( NSC 27435;Catecholcarboxylic acid;Pyrocatechuic acid;23-Dihydroxybenzoic acid;O-Pyrocatechuic acid;3-Hydroxysalicylic acid )

Catalog No. M19589 CAS No. 303-38-8

Pyrocatechuic acid is a normal human benzoic acid metabolite found in plasma and has increased levels after aspirin ingestion.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 37 In Stock
500MG 86 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    23-Dihydroxybenzoic acid
  • Note
    Research use only not for human use.
  • Brief Description
    Pyrocatechuic acid is a normal human benzoic acid metabolite found in plasma and has increased levels after aspirin ingestion.
  • Description
    Pyrocatechuic acid is a normal human benzoic acid metabolite found in plasma and has increased levels after aspirin ingestion.
  • Synonyms
    NSC 27435;Catecholcarboxylic acid;Pyrocatechuic acid;23-Dihydroxybenzoic acid;O-Pyrocatechuic acid;3-Hydroxysalicylic acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    303-38-8
  • Formula Weight
    154.12
  • Molecular Formula
    C7H6O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:194.7 mM
  • SMILES
    OC(=O)c1cccc(O)c1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.A J Trygg J et al. Extraction and GC/MS analysis of the human blood plasma metabolome. Anal Chem. 2005 Dec 15;77(24):8086-94.
molnova catalog
related products
  • Tectorigenin-7-O-bet...

    The roots of Pueraria lobata.

  • 3,5-Diiodo-L-tyrosin...

    3,5-Diiodo-L-tyrosine dihydrate is a natural product.

  • Uprosertib

    Uprosertib (GSK2141795) is a selective, ATP-competitive, and orally bioavailable Akt inhibitor with IC50 of 180 nM, 328 nM, and 38 nM for Akt 1, 2 and 3, respectively. Phase 2.